Addiction Category Archives — DC Medical Malpractice & Patient Safety Blog Published by Washington, D.C. Personal Injury Lawyers

September 16, 2020

Opioid crisis worsens during pandemic, and vaping shrinks to its hard-core

The Covid-19 pandemic has complicated the already difficult efforts to combat substance abuse: New reports affirm how opioid abuse and drug overdoses are soaring, and vaping, while showing favorable declines for the first time in years, also may be creating a hard-core group of nicotine-addicted young people.

With powerful painkillers, the Wall Street Journal reported:

“Counties in states spanning the country, from Washington to Arizona and Florida, are reporting rising drug fatalities this year … This follows a likely record number of deadly overdoses in the U.S. last year, with more than 72,000 people killed, according to federal projections.”

August 9, 2020

With 18 billion reasons to doubt Big Pharma, president’s fiats seem iffy, too

by Patrick A. Malone

For those trying to clean up the costly harms that Big Pharma inflicts on Americans, the how-to details not only matter, they can be confounding. For evidence, just ask federal court officials trying to unravel part of the finances of the opioid and overdose crisis, or the Trump Administration’s soggy efforts to deal with skyrocketing prescription drug prices and scary medication shortages.

The latest bedeviling development in the long crackdown on destructive and highly potent prescription painkillers involves Purdue Pharma, the maker of the addictive drug OxyContin, and the U.S. Justice Department.

For months now, courts in New York and Cleveland have sought to negotiate a “global settlement” of thousands of lawsuits, consolidated first in a federal court in Ohio, and claiming that states, counties, cities, Indian tribes, and others have suffered costly harm due to the opioid abuse and overdose crisis.

July 9, 2020

Opioid abuse and overdoses surge anew, worsened by Covid-19 pandemic

by Patrick A. Malone

With the novel coronavirus crushing the economy and helping to fuel joblessness, individuals’ isolation, and increasing hopelessness and despair among the already troubled, the opioid drug abuse and overdose crisis again is worsening — and fast.

As the Washington Post reported of what had been one of the nation’s leading public health nightmares before the Covid-19 pandemic:

“In Roanoke County, Va., police have responded to twice as many fatal overdoses in recent months as in all of last year. In Kentucky, which just celebrated its first decline in overdose deaths after five years of crisis, many towns are experiencing an abrupt reversal in the numbers. Nationwide, federal and local officials are reporting alarming spikes in drug overdoses — a hidden epidemic within the coronavirus pandemic.

April 30, 2020

Guns, pot, booze, and ‘benzos’: Big concerns in the pandemic’s home stays

by Patrick A. Malone

As Americans have hunkered down to safeguard themselves from Covid-19 infection, too many people also have stocked their homes with potentially harmful items — and the nation soon may be reckoning with the health consequences.

Will consumers come to regret that officials, locality by locality, deemed “essential” and chose to keep open marijuana shops, gun dealers, and liquor stores? Will doctors rue their decision to support patients, understandably unnerved by the pandemic, with a spike in prescriptions of potent and problematic anti-anxiety drugs?

Experts are sounding the alarms — with reasons worth wide public reminder.

April 24, 2020

Celebrity doctors are shoveling loads of unfounded Covid-19 nonsense

by Patrick A. Malone

Even as countless health care workers put themselves at risk and display courage, professionalism, and compassion in caring for Covid-19 patients, a growing collection of colleagues are showering themselves in shame, showing that the credential M.D. may stand for master of dubiousness or Ph.D. is someone whose nonsense is piled high and deep.

As the folks at the HealthNewsReview.org warned a “desperate public,” too ready to embrace self-promoting doctors and others because they are hungry for purported expertise as a pandemic sweeps the globe:

“Beware these red flags: partisan and hyperbolic language and hawking of unproven treatments that seem too good to be true. Seek solid advice from longtime public health institutions: the [federal Centers of Disease Control and Prevention] and the World Health Organization. Understand that because this disease is novel, information is rapidly changing and often tenuous – uncertainties that can be exploited for fame and fortune.”

April 9, 2020

Global vaping snub suggests other nations are learning from United States’ bad example

by Patrick A. Malone

Here’s a glimmer of good health news: It seems that nations around the world may be avoiding what, just a blink ago, was one of the United States’ significant public health concerns — vaping and e-cigarettes.

Juul, the San Francisco-based company at the heart of this controversy, has seen doors shut in its face as it tries to expand its U.S.-curtailed business, the New York Times reported:

“The company has been met with ferocious anti-vaping sentiment and a barrage of newly enacted e-cigarette restrictions, or outright bans, in country after country. As a result, its ambitious overseas plans have collapsed. Juul was kicked off the market in China last fall after just four days. The company has had to abandon plans for India after the government there banned all electronic cigarettes. Thailand, Singapore, Cambodia and Laos have also closed the door to e-cigarettes. In the Philippines, President Rodrigo Duterte ordered the arrest of anyone caught vaping outside designated smoking areas. Juul has postponed its launch in the Netherlands and has pulled out of Israel. In South Korea, the number of Juul customers has plummeted after the government issued dire health warnings about e-cigarettes, and the company has scaled back its distribution there.”

April 2, 2020

Corporate titans faulted for playing dubious roles in opioid-overdose crisis

by Patrick A. Malone

Walmart and Johnson and Johnson, two of America’s corporate titans, each acted in ways that helped to fuel the opioid crisis that federal experts estimate claims 128 Americans’ lives each day, news media investigations show.

Walmart ignored repeated complaints from its own pharmacists and permitted the over-subscribing of hundreds of thousands of potent prescription painkillers by sketchy doctors across the country, with the company’s refusal to deal with rising problems leading federal prosecutors to ready hefty civil and criminal cases, according to ProPublica, a Pulitzer Prize-winning investigative site.

The retailing giant, however, pulled powerful political strings, with Trump Administration officials stepping in to stymie potential lawsuits and criminal charges against Walmart — despite a previously secret settlement the company earlier had signed, pledging to step up its oversight of prescription drugs it sold, ProPublica reported. Reporters Jesse Eisinger and James Bandler wrote:

March 20, 2020

Alcoholics Anonymous can benefit many with drinking problems, research finds

by Patrick A. Malone

Although federal experts estimate that alcohol abuse leads to 88,000 Americans’ deaths annually and economic costs of almost $250 billion, one of the nation’s oldest and best-known programs to deal with this problematic behavior has long been surrounded by doubts.

Critics have questioned its effectiveness, criticized its “irrationality,” and focused on its stepped regimen, desperate and self-enrolling participants, and core tenets, including its spiritual appeals to higher and external powers.

But after a deep dig into the building and rigorous evidence about it — including scrutiny of 27 studies, (some of them randomized clinical trials) with more than 10,000 participants — researchers from Harvard, Stanford, and Europe have concluded in a published, research review for the respected Cochrane Collaboration that Alcoholics Anonymous, indeed, can be beneficial for many but not all excessive alcohol users.

March 10, 2020

All U.S. adults are urged to get hepatitis C test, as opioid crisis-infections spike

by Patrick A. Malone

The opioid-overdose crisis has not disappeared, not by a long shot, and there’s a new warning about its toll: A blue-ribbon expert panel has urged doctors to expand testing for hepatitis C to all adults, ages 18 to 79, and no longer limiting the screening to those born between 1945 and 1965. That’s because the risky conduct that goes with abusing opioids also bumps up the risk of this potentially deadly but treatable liver infection.

Hepatitis C is growing as a significant health concern, the New York Times reported:

“Despite substantial advances in treatment over the past five years, infections are on the rise. Roughly 44,700 new hepatitis C infections were reported in the United States in 2017, according to federal data. A major challenge for health officials is that a significant number of people have the virus but do not know they are infected … Hepatitis C leads to chronic liver disease in most people who contract it, and some eventually develop cirrhosis and liver cancer. It is spread primarily through the sharing of needles among people who use illicit drugs.”

March 3, 2020

Drug maker to pay $1.6 billion to settle claims over its big role in opioids crisis

by Patrick A. Malone

The civil justice system has scored a win in curtailing what once was a major maker of much abused and lethal prescription painkillers: Mallinckrodt, a global drug making giant, has agreed to send its opioids-making generics division into bankruptcy as part of a $1.6 billion settlement to settle thousands of opioid damage claims by state and local governments.

As the New York Times reported of the hefty deal:

“The agreement was endorsed by 47 states and U.S. territories along with a committee of lawyers representing thousands of cities and counties … The money, to be paid into a cash trust over eight years, will be used to underwrite the costs of opioid addiction treatments and related efforts across the country … Under the terms of the agreement, the United States division of Mallinckrodt that produces generic opioids would file for Chapter 11 bankruptcy. After a bankruptcy judge approves the restructuring plan, an initial payment of $300 million would be disbursed to plaintiffs to alleviate the opioid crisis, with the remaining $1.3 billion to be paid out over eight years. Other divisions of the company, which has its headquarters abroad and also produces branded drugs, are not filing for bankruptcy. Mallinckrodt is the first opioid company to reach even a tentative national settlement agreement with municipal governments and most of the states.”